Found: 27
Select item for more details and to access through your institution.
Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00389-2
- By:
- Publication type:
- Article
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 12, p. 2088, doi. 10.1093/cid/ciac345
- By:
- Publication type:
- Article
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e2932, doi. 10.1093/cid/ciaa1280
- By:
- Publication type:
- Article
Variant-Specific IgA Protects Against Omicron Infection.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e287, doi. 10.1093/infdis/jiad525
- By:
- Publication type:
- Article
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 8, p. 1, doi. 10.1002/cti2.1403
- By:
- Publication type:
- Article
Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 2, p. 1, doi. 10.1002/cti2.1241
- By:
- Publication type:
- Article
Systematic analysis of disease‐specific immunological signatures in patients with febrile illness from Saudi Arabia.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 8, p. 1, doi. 10.1002/cti2.1163
- By:
- Publication type:
- Article
Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 7, p. 1, doi. 10.1002/cti2.1160
- By:
- Publication type:
- Article
Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 7, p. 1, doi. 10.1002/cti2.1159
- By:
- Publication type:
- Article
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 6, p. 1, doi. 10.1093/ofid/ofab156
- By:
- Publication type:
- Article
Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 9, p. 1, doi. 10.1093/ofid/ofaa375
- By:
- Publication type:
- Article
Crosstalk between CD64<sup>+</sup>MHCII<sup>+</sup> macrophages and CD4<sup>+</sup> T cells drives joint pathology during chikungunya.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 3, p. 641, doi. 10.1038/s44321-024-00028-y
- By:
- Publication type:
- Article
Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 3, p. 1, doi. 10.15252/emmm.202115227
- By:
- Publication type:
- Article
Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114045
- By:
- Publication type:
- Article
Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
- Published in:
- Journal of Clinical Immunology, 2022, v. 42, n. 2, p. 214, doi. 10.1007/s10875-021-01142-z
- By:
- Publication type:
- Article
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-19080-6
- By:
- Publication type:
- Article
Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID‐19) resolves 2 years after infection.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 5, p. 1, doi. 10.1002/jmv.28774
- By:
- Publication type:
- Article
Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28258
- By:
- Publication type:
- Article
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32312-1
- By:
- Publication type:
- Article
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44524-0
- By:
- Publication type:
- Article
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16638-2
- By:
- Publication type:
- Article
Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-49231-w
- By:
- Publication type:
- Article
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-46800-x
- By:
- Publication type:
- Article
Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.710217
- By:
- Publication type:
- Article
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.680188
- By:
- Publication type:
- Article
A Sensitive Method for Detecting Zika Virus Antigen in Patients' Whole-Blood Specimens as an Alternative Diagnostic Approach.
- Published in:
- 2017
- By:
- Publication type:
- journal article